Latest News

Mahindra and Manulife Insurance JV Moves Ahead; Gets Approval from Ministry of Corporate Affairs

Entity to be called "Mahindra Manulife Insurance Limited"; a 50:50 partnership MUMBAI and HONG KONG, June 2, 2026 /PRNewswire/ -- Mahindra and Manulife announced their partnership to create a life insurance business on November 12, 2025. Both companies have confirmed the incorporation of the JV c...

2026-06-01 09:16 5403

Investor repositioning drives shift in Asia quant markets, BofA Securities conference shows

Key points * BofA Securities hosted its second annual Asia Pacific Integrated Quant Services Senior Leadership Conference in Hong Kong, convening more than 110 senior practitioners. * Discussions highlighted a shift in Asia's quant markets, with rising allocator interest, higher trading volu...

2026-06-01 09:15 4073

Hankook's Ventus Delivers Unwavering Performance Throughout WRC FORUM8 Rally Japan's Ever-Changing Conditions

* Round 7 of the 2026 WRC unfolded across the Aichi and Gifu regions of Japan, featuring fierce competition on rugged mountain stages * Ventus Z215 and Z210 rally tires delivered stable grip and consistent performance in rapidly changing road conditions * Round 8 of the 2026 WRC season, EKO ...

2026-06-01 09:10 3804

Calibrite Display Plus HL Receives Apple Approval for Hardware-Level Display Calibration

For the first time, creative professionals can calibrate Apple displays at hardware level — with a colorimeter priced for working creatives NORTH WHITE PLAINS, N.Y., June 1, 2026 /PRNewswire/ -- Calibrite, the global color management brand trusted by photographers, filmmakers, and designers worl...

2026-06-01 09:00 2832

Traveloka 6.6 Mid Year Sale: Up to S$66 Off Flights, Hotels and Attractions for Singapore Travelers

Traveloka's 6.6 Mid Year Sale Unlocks $66 Sitewide Discounts and 1-for-1 Attraction Deals SINGAPORE, June 1, 2026 /PRNewswire/ -- Traveloka, Southeast Asia's leading travel tech platform, today announced its 6.6 Mid Year Sale that runs from 2 to 9 June 2026, offering Singapore travelers up to S$...

2026-06-01 09:00 3538

Deloitte appoints Robert Hillard as Asia Pacific Chief Executive Officer

HONG KONG, June 1, 2026 /PRNewswire/ -- Deloitte Asia Pacific today announced the appointment of Robert Hillard as Asia Pacific Chief Executive Officer, commencing a four-year term. Mr Hillard's appointment was endorsed by partners across Asia Pacific, and he succeeds David Hill following the com...

2026-06-01 09:00 3324

BofA Securities Asia Forum Gathers Global Investors Amid Surge in Hedge Funds Allocations

Key points * BofA Securities hosted its fourth annual Asia Alternatives Forum, bringing together more than 20 hedge fund managers and 120 institutional allocators. * Allocators of approximately $700 billion in hedge fund capital discussed market conditions and investment strategies. * A Bof...

2026-06-01 09:00 4449

UOB and FPT sign MoU to advance AI, technology transformation and financial innovation opportunities

SINGAPORE, June 1, 2026 /PRNewswire/ -- UOB and global technology corporation FPT have signed a Memorandum of Understanding (MoU) to explore strategic collaboration opportunities in artificial intelligence (AI), digital and technology transformation, and financial services innovation.

2026-06-01 09:00 3547

MICROIP to Debut "AI Vehicle System Business Group" and Edge AI Innovations at COMPUTEX 2026

TAIPEI, June 1, 2026 /PRNewswire/ -- MICROIP (TPEx: 7796), specializing in AI software and ASIC design services, will unveil its "AI Vehicle System Business Group" at COMPUTEX 2026 (Booth A1215a, TWTC Hall 1, June 2-5). Echoing the "AI Together" theme, the showcase focuses on edge AI, smart mobil...

2026-06-01 08:00 4023

D3 Bio Presents First-Line Data for Elisrasib (D3S-001) at ASCO 2026; Next-Generation KRAS G12C Inhibitor Shows Landmark Efficacy in Untreated NSCLC

Elisrasib monotherapy delivers an ORR of 78.0% and median PFS of 12.4 months in first-line KRAS G12C–mutant NSCLC (n=41) across all PD-L1 expression levels Combination of elisrasib with pembrolizumab achieves an ORR of 81.3% in first-line KRAS G12C–mutant NSCLC (n=48) across all PD-L1 expression ...

2026-06-01 08:00 2831

Jyong Biotech CEO Outlines FDA Pathway and Global Strategy in PharmaBoardroom Live Interview

TAIPEI, June 1, 2026 /PRNewswire/ -- Jyong Biotech Ltd. (Nasdaq: MENS) (the "Company" or "Jyong Biotech"), a science-driven biotechnology company dedicated to the development and commercialization of innovative plant-derived therapeutics, today highlighted a strategic vision detailed by its found...

2026-06-01 08:00 2876

AMD Bundles Carbice Ice Pad with Ryzen™ 7 5800X3D

* The Carbice Ice Pad provides a reliable, peel-and-stick, maintenance-free thermal paste alternative designed for consistent gaming performance over the life of a system * Partnership marks the first time consumers can experience advanced carbon nanotube CPU cooling through a mainstream reta...

2026-06-01 08:00 1921

Carbice and Noctua Partner to Bring Advanced Thermal Pad Technology to DIY PC Builders

Noctua is the exclusive retail distributor of Carbice® IP90 thermal pads for the DIY PC market, beginning with the NT-CP1 AM5/4 for AMD Ryzen™ processors ATLANTA, June 1, 2026 /PRNewswire/ -- Carbice

2026-06-01 08:00 2124

Lynk Pharmaceuticals Announces NMPA Approval of LNK01004 Ointment's Phase II Clinical Trial for the Treatment of Vitiligo and Chronic Hand Eczema

HANGZHOU, China, SHANGHAI and BOSTON, June 1, 2026 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. ("Lynk Pharmaceuticals"), a clinical-stage innovative drug development company focused on immune and inflammatory diseases, today announced that its internally developed Class 1 innovative drug candi...

2026-06-01 08:00 3521

BLUETTI Launches EOFY Sale on Power Solutions with Up to 44% OFF

SYDNEY, June 1, 2026 /PRNewswire/ -- Clean energy leader BLUETTI is unleashing massive EOFY deals during June 1–30, up to 44% off its diverse portable power stations and home backup systems.The world's s...

2026-05-31 22:00 3358

Relief as Firmable locates 15,000 accounting decision-makers reported missing at leading global B2B data provider

Sydney-based sales team initiates platform support ticket after discovering significantly more contacts than expected. Investigation concludes that data is correct. MELBOURNE, Australia and SINGAPORE, May 31, 2026 /PRNewswire/ -- Firmable, Asia-Pacific's leading AI-native sales platform, has con...

2026-05-31 20:57 2766

AI: Digital to Physical | BEYOND Expo 2026 Leads Transformative Global Direction of Tech

MACAO, May 31, 2026 /PRNewswire/ -- The BEYOND Expo 2026 has shown what the future looks like as it delivers on its mission of 'Empowering Asia, Bridging the World' with a heavyweight showcase of the latest emerging technology and ideas from Asia. Held at The Venetian Cotai Expo with the theme "A...

2026-05-31 14:32 3477

Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab for First-Line Treatment of PD-L1-Positive NSCLC Published in The Lancet

CHENGDU, China, May 31, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company", 6990.HK) announced today that the results of the Phase III clinical study OptiTROP-Lung05, evaluating the company's trophoblast cell-surface antigen 2 (TROP2)-directed antibody drug con...

2026-05-31 08:00 5700

THE KILLERS ROCK THE UEFA CHAMPIONS LEAGUE FINAL KICK OFF SHOW PRESENTED BY PEPSI®

Millions of fans from across the world tuned in to watch the iconic rock band's unmissable performance ahead of the showpiece fixture of the club football season. BUDAPEST, Hungary, May 31, 2026 /PRNewswire/ -- #PEPSIKICKOFFSHOW – Global superstars The Killers delivered an exceptional headline p...

2026-05-31 03:05 3969

The Results of Phase III OptiTROP-Lung05 Study of Sacituzumab Tirumotecan (sac-TMT) Presented as an ASCO Oral Presentation and Simultaneously Published in The Lancet

CHENGDU, China, May 30, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company", 6990.HK) announced today that at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, the results of the Phase III clinical study OptiTROP-Lung05, evaluating...

2026-05-30 22:01 6209
1 ... 26272829303132 ... 3782